Telegram Trading Scam Tricks Kochi Pharma Firm Owner Into Losing Rs 25 Crore

Published On 2025-09-02 12:08 GMT   |   Update On 2025-09-02 12:08 GMT
Advertisement

Kochi: A 49-year-old pharmaceutical company owner from Elamkulam has reportedly lost Rs 25 crore in an online investment scam, marking one of Kerala's largest individual financial frauds. The victim, an experienced stock market investor, was allegedly lured by promises of exceptionally high returns, including doubling his investment.

According to the Kochi City Police, the fraudster introduced himself as 'Daniel' and first contacted the victim in March 2023 through Telegram. Over time, 'Daniel' convinced the victim to invest in an online trading platform named 'Capitalix' , promising substantial profits from purchasing shares of high-value companies at minimal investment.

Initially, the victim deposited Rs 2 crore and was presented with forged documents showing a profit of approximately Rs 4 crore. Gradually, following the fraudster's instructions, the victim transferred a total of Rs 24.76 crore to various bank accounts between March 15, 2023, and August 29, 2025.

The New Indian Express reports that the fraud came to light when the victim attempted to sell the shares and realized that the trading platform was fake. The Kochi City Police have registered a case under charges of cheating and criminal breach of trust as per the Bharatiya Nyaya Sanhita (BNS). Investigations are ongoing.

Advertisement

Kochi City Police Commissioner Putta Vimaladitya emphasized the importance of remaining alert and cautious while engaging in any online financial activity. He noted that this case is a typical example of financial loss stemming from online trading scams that prey on individuals seeking high returns.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News